Safety and efficacy of ultrasound-enhanced thrombolysis: a comprehensive review and meta-analysis of randomized and nonrandomized studies

…, M Rubiera, TN Sergentanis, K Vadikolias, V Larrue… - Stroke, 2010 - Am Heart Assoc
Background and Purpose—Ultrasound-enhanced thrombolysis is a promising new approach
to facilitate reperfusion therapies for acute ischemic stroke. So far, 3 different ultrasound …

Isolated acute nontraumatic cortical subarachnoid hemorrhage

…, L Calviere, N Raposo, V Larrue… - American journal …, 2010 - Am Soc Neuroradiology
Our aim was to review the etiologic background of isolated acute nontraumatic cSAH. While
SAH located in the basal cisterns originates from a ruptured aneurysm in approximately 85% …

[HTML][HTML] The contribution of virtual reality to the diagnosis of spatial navigation disorders and to the study of the role of navigational aids: A systematic literature review

…, B N'Kaoua, A Tarruella, E Klinger, F Larrue… - Annals of physical and …, 2017 - Elsevier
Introduction Spatial navigation, which involves higher cognitive functions, is frequently
implemented in daily activities, and is critical to the participation of human beings in mainstream …

[HTML][HTML] Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

…, A Dávalos, D Guidetti, V Larrue… - New England journal …, 2008 - Mass Medical Soc
Background Intravenous thrombolysis with alteplase is the only approved treatment for acute
ischemic stroke, but its efficacy and safety when administered more than 3 hours after the …

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)

…, R Von Kummer, A Davalos, D Meier, V Larrue… - The Lancet, 1998 - thelancet.com
Background Thrombolysis for acute ischaemic stroke has been investigated in several
clinical trials, with variable results. We have assessed the safety and efficacy of intravenous …

Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study

…, MG Hennerici, M Kaste, S Kuelkens, V Larrue… - The Lancet, 2007 - thelancet.com
Background The aim of the Safe Implementation of Thrombolysis in Stroke-Monitoring Study
(SITS-MOST) was to assess the safety and efficacy of intravenous alteplase as thrombolytic …

[HTML][HTML] Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis

…, T Moulin, JP Becquemin, V Larrue… - … England Journal of …, 2006 - Mass Medical Soc
Background Carotid stenting is less invasive than endarterectomy, but it is unclear whether
it is as safe in patients with symptomatic carotid-artery stenosis. Methods We conducted a …

Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the …

V Larrue, R von Kummer, A Müller, E Bluhmki - Stroke, 2001 - Am Heart Assoc
Background and Purpose—Intravenous thrombolysis with recombinant tissue plasminogen
activator (rtPA) improves the outcome for ischemic stroke patients who can be treated within …

Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for …

HS Markus, DW Droste, M Kaps, V Larrue, KR Lees… - Circulation, 2005 - Am Heart Assoc
Background— Evidence for efficacy of dual antiplatelet therapy in stroke is limited.
Symptomatic carotid stenosis patients are at high risk of early recurrent stroke. In this group, …

Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative …

…, S Bastianello, R von Kummer, GJ del Zoppo, V Larrue… - Stroke, 1999 - Am Heart Assoc
Background and Purpose—The clinical correlates of the varying degrees of early
hemorrhagic transformation of a cerebral infarct are unclear. We investigated the cohort of a …